Kazunari K. Yokoyama

Professor
Medicine
Kaohsiung Medical University
China

Professor Medicine
Biography

Dr. Kazunari K. Yokoyama received his Ph.D. from University of Tokyo. Currently, he is working as Professor in Institute of medicine of Kaohsiung Medical University. He is specialized in .Human gene therapy, Chromatin regulation on self-renewal and differentiation of stem cells. He won Medal prize in China Medical University, Medal prize in Shanghai Biotechnology Association, Prize in Fudan University, Genetic Institute Prize in Secondary Military Medical University, Honorary Professor of China Medical University, Shenyang, China.

Research Intrest

Chromatin regulation on self-renewal and differentiation; Oxidative stress and anti-oxidation for replicative senescence, stemness and pluripotency; Human gene therapy (virus, small molecules and nucleic acids)

List of Publications
Wang LT, Chiou SS, Chai CY, Hsi E, Chiang CM, Huang SK, Wang SN, Yokoyama KK, Hsu SH. Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer. Oncogene. 2017 Aug;36(31):4405-4414.
Kuo TF, Chen TY, Jiang ST, Chen KW, Chiang YM, Hsu YJ, Liu YJ, Chen HM, Yokoyama KK, Tsai KC, Yeh HH, Chen YR, Yang MT, Yang CY, Yang WC. Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway. Oncogene. 2017 May 22.
Wang LT, Chiou SS, Chai CY, Hsi E, Yokoyama KK, Wang SN, Huang SK, Hsu SH. Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression. Cancer research. 2017 Aug 1;77(15):4065-4077.
Pan XY, Tsai MH, Wuputra K, Ku CC, Lin WH, Lin YC, Kishikawa S, Noguchi M, Saito S, Lin CS, Yokoyama KK. Application of Cancer Cell Reprogramming Technology to Human Cancer Research. Anticancer research. 2017 Jul;37(7):3367-3377.